Article Text

PDF
Amoxycillin - a new antibiotic

Abstract

Amoxycillin (Amoxil) is a new penicillin which differs from ampicillin only in possessing a hydroxyl group on the side chain. In vitro the drugs have identical antibacterial activity and cross-resistance is complete.1 Nevertheless the manufacturers make only a cursory comparison between features of the two antibiotics in their promotional literature. This is a serious omission, since a new antibiotic should not be launched with so little reference to the yard-stick by which it will inevitably be assessed, namely the manner in which it compares with the well-tried ampicillin, over which it may have certain advantages. Bencard, which markets Amoxil is in fact a subsidiary of Beecham, the makers of ampicillin.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.